KaydedilenlerDerginizi ekleyin

Dergiler / Turkish Journal of Medical Sciences / 2020 / Cilt: 50 - Sayı: 4

The effect of vitamin D status on different neuromuscular blocker agents reverse time

İlknur Suidiye YORULMAZ
Yavuz DEMİRARAN
Onur ÖZLÜ
Burhan DOST
Sayfa
749–755
Yayın Tarihi
2020-08-01
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Statistical analysis was performed on these 4 groups Group neostigmine and vitamin D

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/aim: This study is aimed to investigate the effects of vitamin D levels on sugammadex and neostigmine reversal times.
📊
Temel Bulgular & Veri:Material and methods: Eighty patients between the ages of 18 and 65 years, with ASA I-III status who were undergoing surgery under general anesthesia were included in the study.
💡
Sonuç & Katkı:Statistical analysis was performed on these 4 groups Group neostigmine and vitamin D
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Anesthesia · vitamin D · muscle relaxation

Abstract

Background/aim: This study is aimed to investigate the effects of vitamin D levels on sugammadex and neostigmine reversal times. Material and methods: Eighty patients between the ages of 18 and 65 years, with ASA I-III status who were undergoing surgery under general anesthesia were included in the study. A double blind fashion was used to randomly divide all the patients into two groups. At the end of the operation, sugammadex 2 mg/kg was administered to one group Group sugammadex and atropine and neostigmine was administered to the other group Group neostigmine intravenously. In the data analysis stage, the group was divided into two subgroups according to sugammadex and group neostigmine in itself, with vitamin D levels above and below 30 ng/mL. Statistical analysis was performed on these 4 groups Group neostigmine and vitamin D

🔖

Bu Makaleye Atıf Yap

YORULMAZ, İ. S., DEMİRARAN, Y., ÖZLÜ, O., DOST, B. (2020). The effect of vitamin D status on different neuromuscular blocker agents reverse time. Turkish Journal of Medical Sciences, Cilt: 50 - Sayı: 4, 749–755. https://ajindex.com/articles/113174

Kaynakça (15)

  1. Marcinkowska E. A run for a membrane vitamin D receptor. Biological Signals Receptors 2001; 10(6): 341-349
  2. Nair VP, Hunter JM. Anticholinesterase and anticholinergic drugs. Continuing Education in Anaesthesia Critical Care & Pain 2004; 4: 164-168
  3. Naquib M, Lien CA. Pharmacology of muscle relaxants and their antagonists. In: Miller RD, Eriksson LI, Fleischer LA, Weiner-Kronish JP, Young WL (editors). Miller’s Anesthesia. 7th ed. Philadelphia: Churchill Livingstone Elsevier; 2010. pp. 859-912
  4. Booij LH. Cyclodextrins and the emergence of sugammadex. Anaesthesia 2009; 64(1): 31-37
  5. Lien CA, Eikermann M. Neuromuscular blockers and reversal agents. In: Hemmings HC, Egan TD (editors). Pharmacology and Physiology for Anesthesia Foundations and Clinical Practice. Philadelphia: Elsevier Saunders; 2013. pp. 325-348
  6. Faul F, Erdfelder E, Lang A G, Buchner A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods 2007; 39: 175-191
  7. Holick MF. Vitamin D status: measurement, interpretation and clinical application. Annals of epidemiology. 2009; 19(2): 73-78
  8. Massheimer V, Fernandez LM, Boland R, de Boland AR. Regulation of Ca +2 uptake by 1,25-diydroxyvitamin D3: role of phosphorylation and calmoduline. Molecular and Cellular Endocrinology 1992; 84: 15-22
  9. De Roland AR, Boland RL. Non-genomic signal transduction pathway of vitamin D in muscle. Cellular Signalling 1994; 6: 717-724
  10. Bischoff HA, Stähelin HB, Dick W, Akos R, Knecht M et al. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. Journal of Bone and Mineral Research 2003; 18(2): 343-351
  11. Simpson RU, Thomas GA, Arnold AJ. Identification of 1,25-dihydroxyvitamin D3 receptors and activities in muscle. The Journal of Biological Chemistry 1985 Jul 25; 260(15): 8882-8891
  12. Bischoff HA, Borchers M, Gudat F, Duermueller U, Theiler R et al. In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue. The Histochemical Journal 2001; 33(1): 19-24
  13. Zerwekh J. Blood biomarkers of vitamin D status 1,2,3,4. The American Journal of Clinical Nutrition 2008; 87(4): 1087- 1091
  14. Schott GD, Wills MR. Muscle weakness in osteomalacia. Lancet 1976; 1: 626-629
  15. Miller RD, Van Nyhuis LS, Eger EI, Vitez TS, Way WI. Comperative times to peak effect and duration of action of neostigmine and pyridostigmine. Anesthesiology 1974; 41: 27- 33